Anas Younes: This Blood Cancer Awareness Month, it’s important to highlight the critical need for innovative treatment options for people living with hematological malignancies.
Quoting Anas Younes, Senior Vice President and Global Head of Hematology (Early and Late Stage) Oncology R&D at AstraZeneca, on LinkedIn:
”This Blood Cancer Awareness Month, it’s important to highlight the critical need for innovative treatment options for people living with hematological malignancies.
As a hematologist I was inspired by the strength & resilience of patients even during their most vulnerable time. It is these many experiences that drive my passion to find potential new cures for people living with blood cancers.
Through scientific research and patient insights, we are making progress in our understanding of the complexity of this disease. We are laying the foundation for building innovative treatment strategies using different modalities and platforms that could one day redefine blood cancer care and improve outcomes for patients around the world.
Thank you to the blood cancer community for helping raise awareness and partnering with us as we tirelessly work to create a healthier future.”
Source: Anas Younes/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023